sofidexFor patientsAre you a clinician? Clinical site
Ask Sofi
Listen
Patient SupportEmergencies & Reporting
Log inSign up

Meds & supplements  ›  Nelarabine

Medicine · Nucleoside Metabolic Inhibitor

Nelarabine

Nelarabine injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has…

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
Nelarabine injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has…

What it is used for

ARRANON is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.

Side effects, and when to stop

The following clinically-significant adverse reactions are discussed in greater detail in other sections of the label:

  • Neurologic
  • Hematologic
  • Tumor Lysis Syndrome
  • Effects on Ability to Drive and Use Machines

Who should not take it

None.

Other medicines and interactions

Administration of ARRANON in combination with adenosine deaminase (ADA) inhibitors, such as pentostatin, is not recommended.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Nelarabine; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/nelarabine

APA 7th

sofidex. (2026, August 3). Nelarabine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/nelarabine

AMA 11th

Nelarabine. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/nelarabine

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.